Search
Now showing items 1-10 of 241
Connective tissue amyloidosis in patients referred for orthopedic surgery: CONNECT-AMY study
(Elsevier, 2024-10-25)
Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV),
Instituto de Salud Carlos III, Madrid, Spain
c Servicio de Traumatología, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain
d Servicio de Cirugía Plástica, Complexo...
Structural heart transcatheter interventions in orthotopic cardiac transplant and left ventricular assist devices recipients: a nationwide study
(Elsevier, 2024-07-09)
, Barcelona, Spain
r Cardiology Department, Hospital Miguel Servet, Zaragoza, Spain
s Cardiology Department, Hospital Doctor Negrin, Las Palmas de Gran Canaria, Spain
t Centro de investigación biomédica en red, enfermedades cardiovasculares (CIBERCV...
European Society for Organ Transplantation (ESOT) consensus statement on the use of non-invasive biomarkers for cardiothoracic transplant rejection surveillance
(Frontiera, 2024-06-11)
(CHUAC), Instituto de Investigación Biomédica A Coruña (INIBIC),
Universitade de Coruna (UDC), Centro de Investigación Biomédica en Red—Enfermedades Cardiovasculares/Network
Biomedical Research Center—Cardiovascular Diseases (CIBERCV), La Coruna, Spain, 7...
Klinik für Herz- und Thorakale Gefäßchirurgie, Universitäres Herzzentrum Lübeck, Lübeck, Germany, 8Cardiology Department, University Hospital Ramón y Cajal (Madrid), Centro de Investigación Biomedica en Red—Enfermedades Cardiovasculares (CIBERCV), Madrid...
Klinik für Herz- und Thorakale Gefäßchirurgie, Universitäres Herzzentrum Lübeck, Lübeck, Germany, 8Cardiology Department, University Hospital Ramón y Cajal (Madrid), Centro de Investigación Biomedica en Red—Enfermedades Cardiovasculares (CIBERCV), Madrid...
Predicting the development of heart failure in patients with atrial fibrillation
(Elsevier, 2024-04-22)
,b
a Servicio de Cardiología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto
de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Spain
b Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV...
Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis
(Elsevier, 2024-03-28)
[Abstract] Introduction and objetives: Cardiac amyloidosis (CA) is a disorder associated with high number of hospital admissions. Given the scarce information available, we propose an analysis of the incidence and causes ...
Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy
(Elsevier, 2024-03-26)
,b,c, Borja Souto-Caínzos a,b, María Generosa Crepo-Leiro a,b,c, Roberto
Barriales-Villa a,b,c
a Servicio de Cardiología, Hospital Universitario de A Coruña, A Coruña, Spain
b Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Spain
c...
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain Corresponding author. E-mail address: esteban.martin.alvarez@sergas.es (E. Martín-Álvarez). To the Editor, Cardiac amyloidosis (CA) is a serious...
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain Corresponding author. E-mail address: esteban.martin.alvarez@sergas.es (E. Martín-Álvarez). To the Editor, Cardiac amyloidosis (CA) is a serious...
Redefining the molecular rejection states in 3230 heart transplant biopsies: relationships to parenchymal injury and graft survival
(Elsevier, 2024-03-26)
[Abstract] The first-generation Molecular Microscope (MMDx) system for heart transplant endomyocardial biopsies used expression of rejection-associated transcripts (RATs) to diagnose not only T cell-mediated rejection ...
Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin
(Frontiers, 2024-03-08)
Cardiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo
Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), A Coruña,
Spain, 2Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares...
Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III”, integrated in the “Plan Nacional de Programa Científico, Desarrollo e Innovación Tecnológica 2021–2023”, and funded by the “ISCIII-Subdirección References...
Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III”, integrated in the “Plan Nacional de Programa Científico, Desarrollo e Innovación Tecnológica 2021–2023”, and funded by the “ISCIII-Subdirección References...
Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy
(John Wiley & Sons, 2024-03-04)
Universitario A Coruña (CHUAC): CIBERCV, Universidade da Coruña (UDC), Instituto de Investigacion Biomedicas A Coruña (INIBIC), A Coruña, Spain; 4Pfizer Inc, New York,
NY, USA; 5Pfizer Inc, Groton, CT, USA; 6Pfizer Inc, Collegeville, PA, USA; and 7Department...
Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy
(John Wiley & Sons, 2024-03-04)
Universitario A Coruña (CHUAC): CIBERCV, Universidade da Coruña (UDC), Instituto de Investigacion Biomedicas A Coruña (INIBIC), A Coruña, Spain; 4Pfizer Inc, New York,
NY, USA; 5Pfizer Inc, Groton, CT, USA; 6Pfizer Inc, Collegeville, PA, USA; and 7Department...